The Spanish Association of Biosimilar Medicines (Biosim) has transferred to the National Commission of Markets and Competition (CNMC) its position on the commercialization of biosimilar medicines in pharmacies. The association conveys its position before the public consultation that, within the framework of its study on the marketing and distribution of medicines through pharmacies in Spain, is carried out by the entity.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
